Published in

Oxford University Press, Clinical Kidney Journal, 4(13), p. 684-692, 2020

DOI: 10.1093/ckj/sfaa016

Links

Tools

Export citation

Search in Google Scholar

Proteomic characterization of obesity-related nephropathy

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractBackgroundNephropathy related to obesity lacks a pathophysiological understanding and definite diagnostic pathways by biomarkers.MethodsIn this study we investigated the association between urinary peptides and body mass index (BMI) and renal function in proteome data sets from 4015 individuals.ResultsA total of 365 urinary peptides were identified to be significantly associated with BMI. The majority of these peptides were collagen fragments. In addition, most of the peptides also demonstrated a significant concordant association with estimated glomerular filtration rate (eGFR) in the investigated cohort, with the presence of diabetes exhibiting no significant association. A new classifier was developed, based on 150 urinary peptides, that enabled the distinction of non-obese subjects with preserved kidney function from obese, non-diabetic subjects with eGFR >45 mL/min/1.73 m2 in an independent cohort, with an area under the curve of 0.93.ConclusionsOn a molecular level, the data strongly suggest a link between obesity and fibrosis, which may be a major cause of obesity-related nephropathy.